ロード中...
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.
Atevirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1 and is currently in phase II clinical trials. Atevirdine is most soluble at a pH of < 2, and therefore, normal gastric acidity is most likely necessary for optimal bioa...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC163195/ https://ncbi.nlm.nih.gov/pubmed/8851608 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|